CLOs on the Move

Chrono Therapeutics

www.chronothera.com

 
We provide more. We are building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalized digital support to help people achieve optimal clinical outcomes and lifestyle improvements.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Aplicare

Founded in 1983 and headquartered in Meriden, CT, Aplicare is a market leader in the formulation, production and packaging of topical antiseptic and personal care products for use in today's professional health care setting. Just recently, we expanded

Alfa Wasserman

Alfa Wasserman is a Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Johnson's Medical

Johnson's Medical is a Lehi, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Roush Life Sciences

Roush Life Sciences is a Salem, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.